{"id":"https://openalex.org/W2058748929","doi":"https://doi.org/10.1002/bdd.574","title":"The pharmacokinetics of subcutaneously injected bimosiamose disodium in healthy male volunteers","display_name":"The pharmacokinetics of subcutaneously injected bimosiamose disodium in healthy male volunteers","publication_year":2007,"publication_date":"2007-09-18","ids":{"openalex":"https://openalex.org/W2058748929","doi":"https://doi.org/10.1002/bdd.574","mag":"2058748929","pmid":"https://pubmed.ncbi.nlm.nih.gov/17876866"},"language":"en","primary_location":{"id":"doi:10.1002/bdd.574","doi":"https://doi.org/10.1002/bdd.574","is_oa":false,"landing_page_url":"https://doi.org/10.1002/bdd.574","pdf_url":null,"source":{"id":"https://openalex.org/S57691945","display_name":"Biopharmaceutics & Drug Disposition","issn_l":"0142-2782","issn":["0142-2782","1099-081X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics & Drug Disposition","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Michael Meyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Michael Meyer","raw_affiliation_strings":["Revotar Biopharmaceuticals AG, Neuendorfstr. 24a, D-16761 Hennigsdorf, Germany. m.meyer@revotar-ag.de","Revotar Biopharmaceuticals AG, Neuendorfstr. 24a, D-16761 Hennigsdorf, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Revotar Biopharmaceuticals AG, Neuendorfstr. 24a, D-16761 Hennigsdorf, Germany. m.meyer@revotar-ag.de","institution_ids":[]},{"raw_affiliation_string":"Revotar Biopharmaceuticals AG, Neuendorfstr. 24a, D-16761 Hennigsdorf, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113694411","display_name":"Diana Beyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diana Beyer","raw_affiliation_strings":["Revotar Biopharmaceuticals AG, Neuendorfstr. 24a, D-16761 Hennigsdorf, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Revotar Biopharmaceuticals AG, Neuendorfstr. 24a, D-16761 Hennigsdorf, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000697620","display_name":"Karin Vollhardt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karin Vollhardt","raw_affiliation_strings":["Revotar Biopharmaceuticals AG, Neuendorfstr. 24a, D-16761 Hennigsdorf, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Revotar Biopharmaceuticals AG, Neuendorfstr. 24a, D-16761 Hennigsdorf, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013534210","display_name":"Christiane Woischwill","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christiane Woischwill","raw_affiliation_strings":["Revotar Biopharmaceuticals AG, Neuendorfstr. 24a, D-16761 Hennigsdorf, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Revotar Biopharmaceuticals AG, Neuendorfstr. 24a, D-16761 Hennigsdorf, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080941679","display_name":"Bernd Jilma","orcid":"https://orcid.org/0000-0001-5652-7977","observed_orcids":["https://orcid.org/0000-0001-5652-7977"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Bernd Jilma","raw_affiliation_strings":["Department of Clinical Pharmacology, Medical University of Vienna, Waehringerguertel 18-20, A-1090 Wien, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Medical University of Vienna, Waehringerguertel 18-20, A-1090 Wien, Austria","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044853247","display_name":"G. Wolff","orcid":"https://orcid.org/0000-0002-4458-0700","observed_orcids":["https://orcid.org/0000-0002-4458-0700"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerhard Wolff","raw_affiliation_strings":["Revotar Biopharmaceuticals AG, Neuendorfstr. 24a, D-16761 Hennigsdorf, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Revotar Biopharmaceuticals AG, Neuendorfstr. 24a, D-16761 Hennigsdorf, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":0.4246,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.67946514,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"28","issue":"9","first_page":"475","last_page":"484"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.40380001068115234,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.40380001068115234,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.04650000110268593,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.03999999910593033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8339999914169312},{"id":"https://openalex.org/keywords/subcutaneous-injection","display_name":"subcutaneous injection","score":0.9279999732971191},{"id":"https://openalex.org/keywords/sialic-acid","display_name":"sialic acid","score":0.4950000047683716},{"id":"https://openalex.org/keywords/inflammatory-diseases","display_name":"inflammatory diseases","score":0.527999997138977},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.652999997138977},{"id":"https://openalex.org/keywords/repeated-dosing","display_name":"repeated dosing","score":0.7379999756813049},{"id":"https://openalex.org/keywords/urinary-excretion","display_name":"urinary excretion","score":0.7239999771118164},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.5},{"id":"https://openalex.org/keywords/mean-residence-time","display_name":"mean residence time","score":0.7149999737739563},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.5040000081062317}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8829358816146851},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.7083956003189087},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6640632748603821},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6440637707710266},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5837723612785339},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.49498432874679565},{"id":"https://openalex.org/C2776390293","wikidata":"https://www.wikidata.org/wiki/Q2035485","display_name":"Subcutaneous injection","level":2,"score":0.4815950095653534},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.48012685775756836},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4458061456680298},{"id":"https://openalex.org/C125287762","wikidata":"https://www.wikidata.org/wiki/Q1758948","display_name":"Absorption (acoustics)","level":2,"score":0.4269979000091553},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.33262133598327637},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30283689498901367},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06338885426521301},{"id":"https://openalex.org/C24890656","wikidata":"https://www.wikidata.org/wiki/Q82811","display_name":"Acoustics","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006586","descriptor_name":"Hexanes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006586","descriptor_name":"Hexanes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006586","descriptor_name":"Hexanes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008358","descriptor_name":"Mannose","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008358","descriptor_name":"Mannose","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008358","descriptor_name":"Mannose","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008358","descriptor_name":"Mannose","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019087","descriptor_name":"Selectins","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019087","descriptor_name":"Selectins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/bdd.574","doi":"https://doi.org/10.1002/bdd.574","is_oa":false,"landing_page_url":"https://doi.org/10.1002/bdd.574","pdf_url":null,"source":{"id":"https://openalex.org/S57691945","display_name":"Biopharmaceutics & Drug Disposition","issn_l":"0142-2782","issn":["0142-2782","1099-081X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics & Drug Disposition","raw_type":"journal-article"},{"id":"pmid:17876866","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17876866","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics & drug disposition","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W123566684","https://openalex.org/W1900762885","https://openalex.org/W2004662434","https://openalex.org/W2029018478","https://openalex.org/W2033177618","https://openalex.org/W2038198364","https://openalex.org/W2047992291","https://openalex.org/W2055033432","https://openalex.org/W2092675988","https://openalex.org/W2117119768","https://openalex.org/W2160729253","https://openalex.org/W2160800132","https://openalex.org/W2322850958"],"related_works":["https://openalex.org/W2029018478","https://openalex.org/W2160729253","https://openalex.org/W100609786","https://openalex.org/W2002693918","https://openalex.org/W2024770405","https://openalex.org/W2040471016","https://openalex.org/W2327384225","https://openalex.org/W2100894378","https://openalex.org/W2413881456","https://openalex.org/W2106796945"],"abstract_inverted_index":{"Bimosiamose":[0,21,58,68,155,171],"is":[1],"a":[2],"novel":[3],"synthetic":[4],"pan-selectin":[5],"antagonist":[6],"developed":[7],"for":[8,119],"the":[9,18,61,79,85,93,100,162],"treatment":[10],"of":[11,20,50,67,114,139,150,161],"acute":[12],"and":[13,31,64,78,99],"chronic":[14],"inflammatory":[15],"disorders.":[16],"Therefore":[17],"pharmacokinetics":[19],"disodium":[22,59,156],"were":[23,69,107],"studied":[24],"in":[25,168],"healthy":[26],"male":[27],"volunteers":[28],"after":[29,84,124,146],"single":[30],"multiple":[32,134],"subcutaneous":[33,48],"injections.":[34],"A":[35],"randomized,":[36],"double-blind,":[37],"placebo-controlled":[38],"dose":[39,87],"escalation":[40],"trial":[41],"was":[42,75,165,172],"carried":[43],"out.":[44],"The":[45,71,109],"subjects":[46],"received":[47],"injections":[49],"placebo":[51],"or":[52,55,152],"100,":[53],"200":[54,151],"300":[56,153],"mg":[57,154],"into":[60],"abdomen.":[62],"Plasma":[63],"urine":[65],"concentrations":[66,138],"determined.":[70],"maximum":[72],"plasma":[73],"concentration":[74],"2.17+/-0.70":[76],"microg/ml":[77,83],"AUC(0-infinity)":[80],"11.1+/-2.9":[81],"h":[82,106,118],"highest":[86],"on":[88],"day":[89],"1":[90],"(mean+/-SD).":[91],"For":[92,133],"apparent":[94],"clearance":[95],"CL/f":[96],"28.7+/-7.3":[97],"l/h":[98],"terminal":[101],"half":[102],"life":[103],"t(1/2)":[104],"3.7+/-0.6":[105],"calculated.":[108],"mean":[110],"residence":[111],"time":[112],"MRT(infinity)":[113],"5.5":[115],"to":[116,128],"6.3":[117],"s.c.":[120],"injection":[121],"exceeded":[122],"that":[123],"i.v.":[125],"infusion":[126],"due":[127],"an":[129],"extended":[130],"absorption":[131],"time.":[132],"dosing,":[135],"constant":[136],"pre-dose":[137],"about":[140],"20":[141],"ng/ml":[142],"may":[143],"be":[144],"reached":[145],"two":[147],"subsequent":[148],"doses":[149],"once":[157],"daily.":[158],"Almost":[159],"15%":[160],"administered":[163],"drug":[164],"excreted":[166],"unchanged":[167],"urine.":[169],"Moreover,":[170],"well":[173],"tolerated.":[174]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}